1. Home
  2. SSYS vs VALN Comparison

SSYS vs VALN Comparison

Compare SSYS & VALN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Stratasys Ltd. (Israel)

SSYS

Stratasys Ltd. (Israel)

HOLD

Current Price

$8.14

Market Cap

719.7M

Sector

Technology

ML Signal

HOLD

Logo Valneva SE

VALN

Valneva SE

HOLD

Current Price

$6.59

Market Cap

653.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SSYS
VALN
Founded
1989
2012
Country
United States
France
Employees
N/A
N/A
Industry
Computer peripheral equipment
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
719.7M
653.3M
IPO Year
2012
2021

Fundamental Metrics

Financial Performance
Metric
SSYS
VALN
Price
$8.14
$6.59
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
2
Target Price
$12.33
$15.50
AVG Volume (30 Days)
664.9K
27.6K
Earning Date
05-07-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$4.48
N/A
Revenue Next Year
$3.23
$93.87
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.34
$4.75
52 Week High
$12.78
$12.23

Technical Indicators

Market Signals
Indicator
SSYS
VALN
Relative Strength Index (RSI) 51.21 54.11
Support Level $7.47 $6.29
Resistance Level $8.20 $6.60
Average True Range (ATR) 0.26 0.21
MACD 0.06 -0.07
Stochastic Oscillator 72.16 23.72

Price Performance

Historical Comparison
SSYS
VALN

About SSYS Stratasys Ltd. (Israel)

Stratasys Ltd offers polymer-based 3D printing solutions for designers, engineers, manufacturers, dental and medical professionals, and others. Its 3D printing systems utilize the firm's patented extrusion-based FDM, inkjet-based PolyJet, powder-bed-based SAF, photopolymer-based P3, and Neo stereolithography technologies to enable the production of prototypes, tools, and manufactured goods directly from 3D CAD files or other 3D content. The company's solutions portfolio comprises 3D printing systems, consumables, software, paid parts, and professional services, allowing end-users to effectively print 3D models, tools, and parts. Geographically, it generates maximum revenue from the United States, followed by Europe, Middle East and Africa, Asia-Pacific, and other regions.

About VALN Valneva SE

Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.

Share on Social Networks: